Background Retinal vein occlusion (RVO) is the second most common retinal vascular
disorder that affected 16.4 million people worldwide in 2008. The last decade has seen new …

Inflammation underpins and contributes to the pathogenesis of many retinal degenerative
diseases. The recruitment and activation of both resident microglia and recruited …

The world faces difficulties in terms of eye care, including treatment, quality of prevention,
vision rehabilitation services, and scarcity of trained eye care experts. Early detection and …

OBJECTIVE: To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX
implant; OZURDEX, Allergan, Inc., Irvine, CA) compared with sham in eyes with vision loss …

Retinal vein occlusion (RVO) is a major cause of vision loss. Of the two main types of RVO,
branch retinal vein occlusion (BRVO) is 4 to 6 times more prevalent than central retinal vein …

OBJECTIVE: To evaluate the safety and efficacy of 1 or 2 treatments with dexamethasone
intravitreal implant (DEX implant) over 12 months in eyes with macular edema owing to …

OBJECTIVE: To describe the natural history of branch retinal vein occlusion (BRVO) based
on the best available evidence from the literature. CLINICAL RELEVANCE: Branch retinal …

Background/Purpose: Retinal vein occlusion is the second most common retinal vascular
disorder after diabetic retinopathy and is considered to be an important cause of visual loss …

Inflammation affects the formation and the progression of various vitreoretinal diseases. We
performed a comprehensive analysis of inflammatory immune mediators in the vitreous …

Retinal vein occlusion (RVO) is the most common retinal vascular disease after diabetic
retinopathy. Owing to its multifactorial nature, however, management of this condition …